Quick facts

Sobi's head office is located at the Karolinska Institutet Science Park in Solna, Stockholm, Sweden
Sobi's head office is located at the Karolinska Institutet Science Park in Solna, Stockholm, Sweden

  • Sobi is an international specialty biotechnology company dedicated to rare diseases.                      
  • Revenues derive from product sales and from manufacturing of from ReFacto AF for Pfizer.
  • Our organisation spans 24 countries, delivering therapies to patients in 67 countries across the globe. Europe accounts for 54 per cent of sales.
  • Operations are organised in three business lines: Core Products, Partner Products and ReFacto Manufacturing.
  • Our research and product portfolio is primarily focused on haemophilia, inflammation and genetic and metabolic diseases.
  • The Sobi share is listed on NASDAQ OMX Stockholm (STO:SOBI). 

 

Key financials 2016         SEK M   USD M
Net revenues 5,204   608
EBITA 1,543   180
Cash position 786   92
Gross margin 70 %
No. of employees 760  

 

 

Opouštíte webové stránky SOBI

Společnost SOBI již dále nenese odpovědnost za obsah ani funkčnost internetových stránek jiných subjektů.

Přejete si opustit stránky?

Ano    Ne